Sign in
4

Changes in Ownership

Actinium Pharmaceuticals, Inc. Filed Acc 0001213900-16-012632

Options or other derivatives

  • Chief Medical Officer acquired 50,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

CICIC DRAGAN · Chief Medical Officer

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2016-04-15 Grant or award : show line 1 in the form Options to purchase common stock +50,000 $1.99 $99,500 50,000 D
Loading xslF345X03/f4021815cicic_actinium.xml…